title: Ischemia increases the angiogenic potency of basic fibroblast growth factor (FGF-2).
abstract: The aim of this study was to investigate the angiogenic response to exogenously administered basic fibroblast growth factor (FGF-2) in normal and ischemic skin, using the hairless mouse ear microcirculatory model. The hairless mouse ear is a well-established model for in vivo studies of skin microcirculation. Using this model, angiogenesis- and angiogenesis-associated changes in the microcirculation can be directly and continuously viewed and quantified in a variety of different experimental settings. To create ischemia in the mouse ear, all but one of the three to four feeding vessels nourishing the ear were ligated 3 days prior to a local subdermal injection of FGF-2 (9.3 + 1-0.5 mm/mm2) or saline into the dorsum of the ears. Angiogenesis was quantified by direct observation, at high magnification, of the injection site where increases in total vessel length (TVL) were measured repeatedly over 18 days following injection. We found a significant (P < 0.01) increase in TVL in normal and ischemic ears injected with FGF-2. Saline injection also induced a significant increase in TVL in ischemic ears. However, the angiogenic response to FGF-2 in ischemic ears was significantly stronger than saline alone in ischemic ears or saline or FGF-2 in normal ears. This response could be used clinically to accelerate angiogenesis and thus increase perfusion in ischemic tissue.
authors.affiliation: Department of Traumatology, University of Homberg, Saarland, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Frank
authors.forename: C M
authors.initials: CM
authors.lastname: Carroll
authors.forename: K
authors.initials: K
authors.lastname: Aaranson
authors.forename: L
authors.initials: L
authors.lastname: Ogden
authors.forename: M
authors.initials: M
authors.lastname: Kim
authors.forename: G L
authors.initials: GL
authors.lastname: Anderson
authors.forename: L
authors.initials: L
authors.lastname: Swietzer
authors.forename: S J
authors.initials: SJ
authors.lastname: Bond
authors.forename: E
authors.initials: E
authors.lastname: Uhl
authors.forename: J H
authors.initials: JH
authors.lastname: Barker
mesh_terms: D000818:Animals; D004431:Ear, External / Q000098:blood supply; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage / Q000494:pharmacology*; D007279:Injections, Subcutaneous; D007511:Ischemia / Q000503:physiopathology*; D008297:Male; D051379:Mice; D008812:Mice, Hairless; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D012867:Skin / Q000098:blood supply*; D013268:Stimulation, Chemical
chemical_list: D016222:Fibroblast Growth Factor 2